Inside STAT: Can a new Lyme disease vaccine overcome a history of distrust and failure?

Even though summer may be winding down, concerns about Lyme disease are not abating. Researchers are developing a vaccine and another preventive method called pre-exposure prophylaxis. There are several vaccines available for dogs, but bringing one to market for humans has been a difficult road, since the first and only Lyme vaccine was pulled from the market in 2002 due to low demand, potential side effects, and vaccine mistrust. So is the world ready for a new Lyme vaccine? Mistrust is still an issue, but demand may be higher now. Even though some 30,000 cases of Lyme are reported to the CDC every year, the agency estimates that the true number may be 10 times more. STAT’s Brittany Flaherty has more here.